Cargando…

Monoclonal antibodies targeting CD20

Detalles Bibliográficos
Autores principales:	Chang, Chien-Hsing, Rossi, Edmund A., Goldenberg, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169026/ https://www.ncbi.nlm.nih.gov/pubmed/23493149 http://dx.doi.org/10.4161/mabs.24106

Ejemplares similares

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytosis for Treatment of Lupus
por: Rossi, Edmund A., et al.
Publicado: (2014)

In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
por: Blumenthal, R D, et al.
Publicado: (2008)

Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies
por: Nicolas, Philippe, et al.
Publicado: (2022)

Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination
por: Inaba, Tohru, et al.
Publicado: (2022)

Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
por: Guisado-Vasco, P., et al.
Publicado: (2022)

Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012)

Anti-IL-20 monoclonal antibody inhibited tumor growth in hepatocellular carcinoma
por: Chiu, Yi-Shu, et al.
Publicado: (2017)

Anti-CD20 monoclonal antibodies: reviewing a revolution
por: Casan, J. M. L., et al.
Publicado: (2018)

COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma
por: Nachar, Victoria R., et al.
Publicado: (2023)

Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomas
por: Candon, Sophie, et al.
Publicado: (2021)

Tanezumab: Finally a Monoclonal Antibody for Pain Relief
por: Nair, Abhijit S
Publicado: (2018)

Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer
por: Mao, C, et al.
Publicado: (2010)

Ofatumumab: a novel monoclonal anti-CD20 antibody
por: Lin, Thomas S
Publicado: (2010)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Impact of anti-CD20 monoclonal antibodies on serologic response to BNT162b2 vaccine in B-cell Non-Hodgkin’s lymphomas
por: Marchesi, Francesco, et al.
Publicado: (2021)

Decreased interleukin-35 levels and CD4(+)EBI3(+) T cells in patients with type 1 diabetes and the effects of the antibody against CD20 (rituximab)
por: Ouyang, Han, et al.
Publicado: (2020)

A Patient With CD20-positive T-cell Lymphoma Concurrently Exhibiting B-cell Neoplasm-related Genetic Abnormalities Shows Clonal Escape Post CD20-targeting Treatment
por: Kim, Jiyeon, et al.
Publicado: (2023)

Interferon-λ1 Linked to a Stabilized Dimer of Fab Potently Enhances both Antitumor and Antiviral Activities in Targeted Cells
por: Liu, Donglin, et al.
Publicado: (2013)

Generation of monoclonal antibodies against n-3 fatty acid desaturase
por: Zhang, Yanfei, et al.
Publicado: (2015)

COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view
por: Vitiello, Antonio, et al.
Publicado: (2021)

True effect of monoclonal antibody for COVID-19 in kidney transplant recipients
por: Khatri, Akshay, et al.
Publicado: (2022)

Anti–IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss
por: Hsu, Yu-Hsiang, et al.
Publicado: (2011)

Enhancing the antitumor potency of T cells redirected by bispecific antibodies
por: Chang, Chien-Hsing, et al.
Publicado: (2017)

Bispecific T cell engagers targeting CD20/CD3 in B-cell lymphoma: latest updates from 2023 EHA annual meeting
por: Jin, Shenhe, et al.
Publicado: (2023)

COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified
por: Ferrara, Francesco, et al.
Publicado: (2021)

Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
por: Chavarot, Nathalie, et al.
Publicado: (2022)

Development of monoclonal antibody-based antigens detection assays for orthopoxvirus and monkeypox virus
por: Li, Mengjun, et al.
Publicado: (2022)

Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series
por: Simard, Marie-Lee, et al.
Publicado: (2023)

The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine
por: Jain, Saurabh, et al.
Publicado: (2016)

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
por: Du, Fanny Huynh, et al.
Publicado: (2017)

Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
por: Liu, Donglin, et al.
Publicado: (2014)

Anti‐CD20 monoclonal antibody therapy in postpartum women with neurological conditions
por: Anderson, Annika, et al.
Publicado: (2023)

Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients
por: Tao, T, et al.
Publicado: (2015)

Reply: In vitro and in vivo anticancer efficacy of unconjugated humanised anti-CEA monoclonal antibodies
por: Ashraf, S Q, et al.
Publicado: (2008)

Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
por: Joob, Beuy, et al.
Publicado: (2014)

Monoclonal Antibody Use in Post-Acute and Long-Term Care: A Call to Action
por: Palat, Sing T., et al.
Publicado: (2021)

Simultaneous detection and typing of human metapneumovirus strains in nasopharyngeal secretions and cell cultures by monoclonal antibodies
por: Gerna, Giuseppe, et al.
Publicado: (2006)

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
por: Dillman, R. O.
Publicado: (2006)

Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin
por: Ly, Sophia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mibdeege52bhgq1lqnko6ldfpn